NICE recommends tolvaptan for patients with ADPKD
28 October 2015 | By Victoria White
Tolavptan is the first-ever treatment shown to slow progression of the life-threatening condition...
List view / Grid view
28 October 2015 | By Victoria White
Tolavptan is the first-ever treatment shown to slow progression of the life-threatening condition...
21 October 2015 | By Victoria White
The new draft guidance is different to the original 2007 guidance because it reflects the fact that current clinical practice has a greater emphasis on managing CVD risk rather than meeting target cholesterol levels...
19 October 2015 | By Victoria White
Viekirax and Exviera are the first treatments for chronic HCV to combine three direct-acting antiviral agents to target the infection at multiple steps in the viral lifecycle...